Endoprotesi esofagee autoespansibili: studio di confronto tra Ultraflex e Choostent.

Translated title of the contribution: Self-expanding oesophageal stents: comparison of Ultraflex and Choostent

Davide Bona, Letizia Laface, Stefano Siboni, Moshe Schaffer, Daniela Baldoli, Andrea Sironi, Francesca Sorba, Luigi Bonavina

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Two types of covered self-expanding metal stents were compared in a consecutive series of 57 patients. Stent placement was successful in all patients. No procedure-related deaths were observed. The overall hospital morbidity was 7%. No significant differences in the efficacy of palliation of dysphagia, rate of complications, and survival rates were seen using the two types of stent. An endoscopic reintervention was required in 14% of the patients. Both stents proved to be safely removable in the short term follow-up, and the benefit of temporary insertion was documented in patients with primary oesophageal neoplasms prior to chemotherapy or chemoradiation therapy and in those with anastomotic strictures/leaks. A multidisciplinary strategy, guided by the concept that a stent should not represent the only, definitive treatment modality, may improve the quality of life of patients with advanced oesophageal carcinoma.

Original languageItalian
Pages (from-to)641-646
Number of pages6
JournalChirurgia Italiana
Volume61
Issue number5-6
Publication statusPublished - Sep 2009

Fingerprint

Stents
Anastomotic Leak
Esophageal Neoplasms
Deglutition Disorders
Pathologic Constriction
Survival Rate
Metals
Quality of Life
Morbidity
Carcinoma
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Bona, D., Laface, L., Siboni, S., Schaffer, M., Baldoli, D., Sironi, A., ... Bonavina, L. (2009). Endoprotesi esofagee autoespansibili: studio di confronto tra Ultraflex e Choostent. Chirurgia Italiana, 61(5-6), 641-646.

Endoprotesi esofagee autoespansibili : studio di confronto tra Ultraflex e Choostent. / Bona, Davide; Laface, Letizia; Siboni, Stefano; Schaffer, Moshe; Baldoli, Daniela; Sironi, Andrea; Sorba, Francesca; Bonavina, Luigi.

In: Chirurgia Italiana, Vol. 61, No. 5-6, 09.2009, p. 641-646.

Research output: Contribution to journalArticle

Bona, D, Laface, L, Siboni, S, Schaffer, M, Baldoli, D, Sironi, A, Sorba, F & Bonavina, L 2009, 'Endoprotesi esofagee autoespansibili: studio di confronto tra Ultraflex e Choostent.', Chirurgia Italiana, vol. 61, no. 5-6, pp. 641-646.
Bona D, Laface L, Siboni S, Schaffer M, Baldoli D, Sironi A et al. Endoprotesi esofagee autoespansibili: studio di confronto tra Ultraflex e Choostent. Chirurgia Italiana. 2009 Sep;61(5-6):641-646.
Bona, Davide ; Laface, Letizia ; Siboni, Stefano ; Schaffer, Moshe ; Baldoli, Daniela ; Sironi, Andrea ; Sorba, Francesca ; Bonavina, Luigi. / Endoprotesi esofagee autoespansibili : studio di confronto tra Ultraflex e Choostent. In: Chirurgia Italiana. 2009 ; Vol. 61, No. 5-6. pp. 641-646.
@article{89f5f00ff54a4c29975b262d98543448,
title = "Endoprotesi esofagee autoespansibili: studio di confronto tra Ultraflex e Choostent.",
abstract = "Two types of covered self-expanding metal stents were compared in a consecutive series of 57 patients. Stent placement was successful in all patients. No procedure-related deaths were observed. The overall hospital morbidity was 7{\%}. No significant differences in the efficacy of palliation of dysphagia, rate of complications, and survival rates were seen using the two types of stent. An endoscopic reintervention was required in 14{\%} of the patients. Both stents proved to be safely removable in the short term follow-up, and the benefit of temporary insertion was documented in patients with primary oesophageal neoplasms prior to chemotherapy or chemoradiation therapy and in those with anastomotic strictures/leaks. A multidisciplinary strategy, guided by the concept that a stent should not represent the only, definitive treatment modality, may improve the quality of life of patients with advanced oesophageal carcinoma.",
author = "Davide Bona and Letizia Laface and Stefano Siboni and Moshe Schaffer and Daniela Baldoli and Andrea Sironi and Francesca Sorba and Luigi Bonavina",
year = "2009",
month = "9",
language = "Italian",
volume = "61",
pages = "641--646",
journal = "Chirurgia Italiana",
issn = "0009-4773",
publisher = "Bi & Gi Editori",
number = "5-6",

}

TY - JOUR

T1 - Endoprotesi esofagee autoespansibili

T2 - studio di confronto tra Ultraflex e Choostent.

AU - Bona, Davide

AU - Laface, Letizia

AU - Siboni, Stefano

AU - Schaffer, Moshe

AU - Baldoli, Daniela

AU - Sironi, Andrea

AU - Sorba, Francesca

AU - Bonavina, Luigi

PY - 2009/9

Y1 - 2009/9

N2 - Two types of covered self-expanding metal stents were compared in a consecutive series of 57 patients. Stent placement was successful in all patients. No procedure-related deaths were observed. The overall hospital morbidity was 7%. No significant differences in the efficacy of palliation of dysphagia, rate of complications, and survival rates were seen using the two types of stent. An endoscopic reintervention was required in 14% of the patients. Both stents proved to be safely removable in the short term follow-up, and the benefit of temporary insertion was documented in patients with primary oesophageal neoplasms prior to chemotherapy or chemoradiation therapy and in those with anastomotic strictures/leaks. A multidisciplinary strategy, guided by the concept that a stent should not represent the only, definitive treatment modality, may improve the quality of life of patients with advanced oesophageal carcinoma.

AB - Two types of covered self-expanding metal stents were compared in a consecutive series of 57 patients. Stent placement was successful in all patients. No procedure-related deaths were observed. The overall hospital morbidity was 7%. No significant differences in the efficacy of palliation of dysphagia, rate of complications, and survival rates were seen using the two types of stent. An endoscopic reintervention was required in 14% of the patients. Both stents proved to be safely removable in the short term follow-up, and the benefit of temporary insertion was documented in patients with primary oesophageal neoplasms prior to chemotherapy or chemoradiation therapy and in those with anastomotic strictures/leaks. A multidisciplinary strategy, guided by the concept that a stent should not represent the only, definitive treatment modality, may improve the quality of life of patients with advanced oesophageal carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=77951649146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951649146&partnerID=8YFLogxK

M3 - Articolo

C2 - 20380272

AN - SCOPUS:77951649146

VL - 61

SP - 641

EP - 646

JO - Chirurgia Italiana

JF - Chirurgia Italiana

SN - 0009-4773

IS - 5-6

ER -